IASO-782

· Shanghai IASO Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IASO-782, covering 2024-08-01 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: IASO-782 in Systemic Lupus Erythematosus [Phase 1]